Data / Drug companies / Carlsbad Technology, Inc.
Carlsbad Technology, Inc.: 29 products in the FDA NDC directory, labeler code 61442
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Carlsbad Technology, Inc. (labeler code 61442) lists 29 products in the FDA National Drug Code Directory, covering 11 finished drugs by generic name. By type: 29 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 22, 2025.
The request: Watch Carlsbad Technology, Inc. (FDA labeler code 61442): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 61442
- Products in commercial distribution
- 29
- Packages
- 77
- Finished drugs by generic name
- 11
- Prescription products
- 29
- Over the counter products
- 0
- Flagged as original packager
- 29 of 29 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- November 13, 1998
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 29 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 29 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Diclofenac sodium | 5 | 109 |
| Acyclovir | 3 | 70 |
| Lovastatin | 3 | 22 |
| Ciprofloxacin hydrochloride | 3 | 36 |
| Felodipine | 3 | 15 |
| Glimepiride | 3 | 32 |
| Memantine hydrochloride | 2 | 36 |
| Famotidine | 2 | 138 |
| Meloxicam | 2 | 54 |
| Cefaclor | 2 | 4 |
| Entecavir | 1 | 15 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 13 | 44.8% |
| Tablet, film coated | 8 | 27.6% |
| Tablet, delayed release | 5 | 17.2% |
| Capsule | 3 | 10.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Memantine Hydrochloride | 61442-193 | Tablet, film coated | Generic drugs (ANDA) | June 22, 2025 |
| Memantine Hydrochloride | 61442-192 | Tablet, film coated | Generic drugs (ANDA) | June 22, 2025 |
| Diclofenac Sodium Delayed Release | 61442-227 | Tablet, delayed release | Generic drugs (ANDA) | March 28, 2025 |
| Diclofenac Sodium Delayed Release | 61442-226 | Tablet, delayed release | Generic drugs (ANDA) | March 28, 2025 |
| Entecavir | 61442-311 | Tablet | Generic drugs (ANDA) | November 10, 2021 |
| Felodipine | 61442-433 | Tablet, film coated | Generic drugs (ANDA) | October 12, 2020 |
| Felodipine | 61442-432 | Tablet, film coated | Generic drugs (ANDA) | October 12, 2020 |
| Felodipine | 61442-431 | Tablet, film coated | Generic drugs (ANDA) | October 12, 2020 |
| Acyclovir | 61442-114 | Capsule | Generic drugs (ANDA) | August 17, 2017 |
| Glimepiride | 61442-117 | Tablet | Generic drugs (ANDA) | January 1, 2012 |
| Glimepiride | 61442-116 | Tablet | Generic drugs (ANDA) | January 1, 2012 |
| Glimepiride | 61442-115 | Tablet | Generic drugs (ANDA) | January 1, 2012 |
| Meloxicam | 61442-127 | Tablet | Generic drugs (ANDA) | June 30, 2010 |
| Meloxicam | 61442-126 | Tablet | Generic drugs (ANDA) | June 30, 2010 |
| Acyclovir | 61442-113 | Tablet | Generic drugs (ANDA) | October 22, 2009 |
| Acyclovir | 61442-112 | Tablet | Generic drugs (ANDA) | October 22, 2009 |
| Ciprofloxacin | 61442-224 | Tablet, film coated | Generic drugs (ANDA) | October 10, 2009 |
| Ciprofloxacin | 61442-223 | Tablet, film coated | Generic drugs (ANDA) | October 10, 2009 |
| Ciprofloxacin | 61442-222 | Tablet, film coated | Generic drugs (ANDA) | October 10, 2009 |
| Cefaclor | 61442-172 | Capsule | Generic drugs (ANDA) | July 31, 2008 |
| Cefaclor | 61442-171 | Capsule | Generic drugs (ANDA) | July 31, 2008 |
| Lovastatin | 61442-143 | Tablet | Generic drugs (ANDA) | November 25, 2002 |
| Lovastatin | 61442-142 | Tablet | Generic drugs (ANDA) | November 25, 2002 |
| Lovastatin | 61442-141 | Tablet | Generic drugs (ANDA) | November 25, 2002 |
| Famotidine | 61442-122 | Tablet | Generic drugs (ANDA) | April 16, 2001 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.